Skip to Content
Contact Form Map & Directions Videos

Monthly Archives: October 2012

Florida Facilities That Have Compounding Products

10/22/2012
Defective Drugs
BY

The Florida Department of Health (DOH) has identified a third death associated with a nationwide outbreak of fungal meningitis from a contaminated steroid. The 78-year-old man was from Marion County. He had received an injection of methylprednisolone acetate prepared by the New England Compounding Center (NECC) which is implicated in […]

Read More

CDC Health Alert Network – Meningitis and Stroke

10/18/2012
Announcement
BY

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are coordinating a multi state investigation of the source of the fungal meningitis outbreak that has caused five deaths. These patients, along with thousands of others, had received an epidural steroid injection, preservative-free methylprednisolone acetate […]

Read More

FDA Warning: Mirapex Linked to Heart Failure

10/15/2012
Mass Tort News
BY

Results of recent studies indicate that Mirapex, a drug used to treat Parkinson’s disease and restless leg syndrome, may carry a risk of heart failure. The U.S. Food and Drug Administration (FDA) has not positively identified the risk and is working with the drug’s manufacturer, Boehringer Ingelheim, to conduct a […]

Read More

Who Regulates Compounding Pharmacies?

10/13/2012
Articles
BY

That is the question both the state of Massachusetts and the Food and Drug Administration will be required to answer as the death toll rises to 14 with 170 sickened in 23 states from a contaminated steroid injection. As it turns out both state and federal agencies can regulate the […]

Read More

Compounding Pharmacies – An Unregulated Minefield

10/10/2012
Articles
BY

Compounding Pharmacies The controversy over the fungal meningitis outbreak that is traced to contaminated steroid injections has brought compounding pharmacies under the spotlight. This is not the first time. A compounding pharmacy mixes drugs for use by hospitals and clinics. Often they make up for a shortfall in drugs, as […]

Read More

FDA Adds Authority over Clinical Trials

10/10/2012
Articles
BY

Where, oh where does clinical trial data go? Earlier this year, the British Medical Journal (BMJ) wrote that a large proportion of evidence from human clinical trials goes missing while cherry-picked favorable data appears. According to the BMJ, fewer than half of the data from clinical trials run using National […]

Read More

Hear What Our Clients Have To Say

"Without question, a tier one law firm! I have been extremely pleased with the quality of service and their attention to detail. Everyone has been extraordinarily kind and professional. I highly recommend this fine organization!"
Posted By: Bud Wilder